The Association of VDAC with Cell Viability of PC12 Model of Huntington's Disease

Andonis Karachitos1, Daria Grobys1, Klaudia Kulczyńska1

  • 1Laboratory of Bioenergetics, Faculty of Biology, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University in Poznań , Poznań , Poland.

Frontiers in Oncology
|November 29, 2016
PubMed

Insights

Mutant huntingtin (mHtt) expression alters voltage-dependent anion-selective channel (VDAC) function, impacting mitochondria and cell survival in Huntington

Area of Science:

  • Cell Biology
  • Neuroscience
  • Mitochondrial Biology

Background:

  • Mitochondrial dysfunction is implicated in Huntington's disease (HD) pathogenesis.
  • The precise mechanisms linking mitochondria dysfunction to cell death in HD remain unclear.
  • Voltage-dependent anion-selective channel (VDAC) plays a critical role in mitochondrial function.

Purpose of the Study:

  • To investigate the impact of wild-type huntingtin (Htt) and mutant huntingtin (mHtt) expression on cell survival and mitochondrial function.
  • To determine the effect of Htt and mHtt expression on VDAC function in an inducible PC12 cell model of HD.

Main Methods:

  • Utilized an inducible PC12 cell model expressing Htt and mHtt.
  • Assessed cell viability and mitochondrial function after 48 hours of protein expression.
  • Isolated VDAC and analyzed its function using a black lipid membrane system.

Main Results:

  • Expression of mHtt, but not Htt, altered VDAC's open state conductance and voltage-dependence.
  • VDAC1 was the dominant VDAC isoform, and its relative abundance was unchanged by Htt/mHtt expression.
  • Functional VDAC changes occurred shortly after Htt and mHtt expression.

Conclusions:

  • Htt and mHtt expression-induced functional alterations in VDAC, primarily VDAC1, contribute to mitochondrial dysfunction and reduced cell viability in HD models.
  • These findings offer insights into HD cytotoxicity and potential cytoprotective strategies.